On July 24, Quantinuum declined 5.01% in regular trading, trading at $53.46 per share, with turnover of $13.94 million. The stock has now fallen further below its $60 IPO price as sustained wide-range volatility persists following concentrated initiation of coverage by multiple Wall Street investment banks.

Since June 29, at least ten major banks have initiated coverage on Quantinuum with sharply divergent valuations. Morgan Stanley assigned an Equal Weight rating with a $78 target, while Rosenblatt issued the highest target at $155. JPMorgan initiated at Overweight with a $97 target, BofA Securities and Needham both set $100 targets, and UBS, Jefferies, Mizuho, and Cantor Fitzgerald clustered between $90 and $93. The gap between the lowest and highest targets exceeds 98%, reflecting deep disagreement over the quantum computing platform company's fair value. Meanwhile, fundamental pressures persist, with Q1 revenue declining 73% year-over-year and net losses widening to $136.5 million, contributing to continued selling pressure barely two months after its Nasdaq debut.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)